top of page

Recurrence post-transplant observational study in FSGS & Minimal Change Disease (RESOLVE)

Who's Eligible? 

  • Patients with a diagnosis of FSGS or MCD in their native kidney.

  • Patients who have had or are scheduled to have a kidney transplant. 

​

What's Required? 

  • Patients to provide voluntary, informed consent.

  • Completion of study visits at defined timepoints (i.e., 3-6 visits total)

  • Contribution of self-reported data, electronic health record data, and biospecimens. 

​

Site Locations

  • Ann Arbor, Michigan (USA)

  • Charlotte, North Carolina (USA)

  • Chicago, Illinois (USA)

  • Los Angeles, California (USA)

  • Torrance, California (USA)

  • Vancouver, British Columbia (Canada)

​

​

​

Information for Researchers

This important work cannot be done without collaboration across research institutions, sponsors, advocacy groups, and patients. â€‹If you are a researcher interested in collaboration, please contact us to complete an ancillary study application or inquire about site participation. 

​

bottom of page